| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/30/2001 | US20010018509 Growth differeniation factor-3 |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018212 Molecular weight of 14,000 to 24,000 daltons; treating infectious diseases and malignant tumors with said protein |
| 08/30/2001 | US20010018201 Using hapten |
| 08/30/2001 | US20010018199 Process for preparing a desired protein |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018197 Forming a slurry; washing |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018182 Methods of monitoring disease states and therapies using gene expression profiles |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400710A1 Starch branching enzyme |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397705A1 Compounds related to or derived from gfr.alpha.4 and their use |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127160A2 Parallel methods for genomic analysis |
| 08/29/2001 | EP1127155A1 Enzymatic amidation of peptides |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127142A1 Modulation of polypeptide display on modified filamentous phage |
| 08/29/2001 | EP1127141A1 Method for expressing recombinant proteins using the effect of stress and stress response mechanisms in the presence of compatible solutes |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127112A2 Methods for cloning animals |
| 08/29/2001 | EP1127104A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | EP1127069A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1126912A1 Method and device for carrying out biochemical reactions with a high throughput |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1000089A4 Collagen type i and type iii adhesive compositions |
| 08/29/2001 | EP0792290B1 Acylated insulin |
| 08/29/2001 | EP0754754B1 Fk506-binding protein gene |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | CN1310763A New peptide fragments for protein purification |
| 08/28/2001 | USRE37343 Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences |
| 08/28/2001 | US6281348 A dna encoding a gene that inhibits pollen formation; producing hybrid seeds for commercial sale |
| 08/28/2001 | US6281335 Hybridoma and anti-KC-4 humanized monoclonal antibody |
| 08/28/2001 | US6281332 Hedgehog-derived polypeptides |
| 08/28/2001 | US6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 08/28/2001 | US6281329 Extracting recombinant pro-insulin from inclusion bodies from gram negative bacteria by permeabilizing the membrane with a surfactant or agent that separates the native cell protein, solubilizing the membrane and separating the insulin |
| 08/28/2001 | US6281193 In autoimmune diseases in general, or graft-versus-host reactions in particular. |
| 08/28/2001 | US6281016 Broad-spectrum insect resistant transgenic plants |
| 08/28/2001 | US6280988 Method for detecting Candida infection |
| 08/28/2001 | US6280975 Adjusted interleukin polypeptide for use in the treatment of myelomas, tumors, osteoporosis and autoimmune diseases |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/28/2001 | US6280972 Generating modulator of enzymatic activity; culture cells transformed with expression vector coding enzymatic modulator, recover enzymatic modulator |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280968 Human PEC-60-like protein and DNA encoding the same |
| 08/28/2001 | US6280938 SCA7 gene and method of use |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | US6280731 Monoclonal antibody which binds to human von willebrand factor, inhibits ristocetin-dependent and botrocetin-dependent binding of human von willebrand factor to human platelets, exhibits antithrombotic action in guinea pigs |
| 08/28/2001 | US6280730 Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2111845C Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/28/2001 | CA1341286C Blood substitutes |
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061025A1 Method for increasing the gene expression of transfected genes |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060856A2 Vmglom gene and its mutations causing disorders with a vascular component |
| 08/23/2001 | WO2001060850A1 Novel compounds |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060156A1 Neutralizing antibody and immunomodulatory enhancing compositions |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001007479A3 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 08/23/2001 | WO2001000842A3 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016650 A specific polynucleotide comprising the nucleotide sequence of protein coding sequence of clone AK647 deposited under ATCC 98026; administering to a mammal an antibody reacted to the protein for promoting smooth muscle cell growth |
| 08/23/2001 | US20010016649 Nucleic acids and polypeptides; for diagnosing chondrosarcoma and for drug screening |
| 08/23/2001 | US20010016648 Of given amino acid sequence; for diagnosis, drug screening, producing antibodies; treating autoimmune disorders |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016645 Vitazin antibody; treating angiogenesis or restenosis |